Home › Asset managers › Compare 2025-2026 › American Century vs Brighthouse
Note on Brighthouse: its funds did not all vote the same way on 12.0% of the 120,248 ballot items it voted. Those items are not in the percentage above; the ones it shares with this pair are listed under “Split votes”.
American Century 2025-2026 · Brighthouse 2025-2026 · Download the item list (CSV)
| Common items | Same | Differ | Split (not in %) | Same position | Fund-level | |
|---|---|---|---|---|---|---|
| All ballot items | 66,352 | 54,212 | 1,394 | 10,746 | 97.5% | 91.7% |
| Board proposals | 56,616 | 45,411 | 1,270 | 9,935 | 97.3% | 91.2% |
| E&S shareholder proposals | 173 | 0 | 1 | 172 | 0.0% | 40.1% |
| Other items | 9,563 | 8,801 | 123 | 639 | 98.6% | 95.5% |
Everything Voted differently Split votes
All ballot items Board proposals E&S shareholder proposals Other items
9,935 items. “Voted differently”: each manager’s funds all voted one way, and the two ways differ. “Split”: at least one manager’s funds did not all vote the same way.
| Company | Meeting | Proposal | On the ballot from | Board recommended | American Century | Brighthouse |
|---|---|---|---|---|---|---|
| ARCHER-DANIELS-MIDLAND COMPANY | May 7, 2026 | Election of Directors: M.S. Burke Director Elections |
Board | For | FOR 12 funds |
Split 7 FOR, 2 ABSTAIN |
| ARCHER-DANIELS-MIDLAND COMPANY | May 7, 2026 | Election of Directors: P.J. Moore Director Elections |
Board | For | FOR 12 funds |
Split 7 FOR, 2 ABSTAIN |
| ARCHER-DANIELS-MIDLAND COMPANY | May 7, 2026 | Election of Directors: S.F. Harrison Director Elections |
Board | For | FOR 12 funds |
Split 7 FOR, 2 ABSTAIN |
| ARCHER-DANIELS-MIDLAND COMPANY | May 7, 2026 | Election of Directors: T. Colbert Director Elections |
Board | For | FOR 12 funds |
Split 7 FOR, 2 ABSTAIN |
| ARCHER-DANIELS-MIDLAND COMPANY | May 7, 2026 | Election of Directors: T.K. Crews Director Elections |
Board | For | FOR 12 funds |
Split 7 FOR, 2 ABSTAIN |
| ARCHER-DANIELS-MIDLAND COMPANY | May 7, 2026 | Ratification of Appointment of Ernst & Young LLP as Independent Registered Public Accounting Firm for the Year Ending December 31, 2026. Audit-related |
Board | For | FOR 12 funds |
Split 6 FOR, 1 AGAINST, 2 ABSTAIN |
| ARCHROCK, INC. | April 30, 2026 | Advisory, non-binding vote to approve the compensation provided to our Named Executive Officers for 2025. Say-on-Pay |
Board | For | FOR 8 funds |
Split 3 FOR, 2 ABSTAIN |
| ARCHROCK, INC. | April 30, 2026 | Ratification of the appointment of Deloitte & Touche LLP as Archrock, Inc.'s independent registered public accounting firm for fiscal year 2026. Audit-related |
Board | For | FOR 7 funds |
Split 3 FOR, 2 ABSTAIN |
| ARCOSA, INC. | May 13, 2026 | Advisory vote to approve named executive officer compensation. Say-on-Pay |
Board | For | FOR 3 funds |
Split 6 FOR, 1 ABSTAIN |
| ARCOSA, INC. | May 13, 2026 | Ratification of Ernst & Young LLP as Arcosa's independent registered public accounting firm for the year ending December 31, 2026. Audit-related |
Board | For | FOR 2 funds |
Split 6 FOR, 1 ABSTAIN |
| ARCUS BIOSCIENCES, INC. | June 11, 2026 | To approve, on an advisory basis, the compensation of Arcus Biosciences' named executive officers, as disclosed in the Proxy Statement. Say-on-Pay |
Board | For | AGAINST 3 funds |
Split 2 FOR, 1 ABSTAIN |
| ARCUS BIOSCIENCES, INC. | June 11, 2026 | To ratify the appointment by the Audit Committee of the Board of Directors of Ernst & Young LLP as the independent registered public accounting firm of Arcus Biosciences for its fiscal year ending December 31, 2026. Audit-related |
Board | For | FOR 2 funds |
Split 2 FOR, 1 ABSTAIN |
| ARCUTIS BIOTHERAPEUTICS, INC. | June 5, 2026 | Election of Class III directors to hold office until the 2029 Annual Meeting of Stockholders or until their successors are elected. Patrick J. Heron Director Elections |
Board | For | WITHHOLD 5 funds |
Split 1 FOR, 2 WITHHOLD |
| ARCUTIS BIOTHERAPEUTICS, INC. | June 5, 2026 | To approve, on a non-binding advisory basis, the compensation of the Company's named executive officers. Say-on-Pay |
Board | For | AGAINST 6 funds |
Split 2 FOR, 1 ABSTAIN |
| ARCUTIS BIOTHERAPEUTICS, INC. | June 5, 2026 | To ratify the selection, by the Audit Committee of the Company's Board of Directors, of Ernst & Young LLP, as the independent registered public accounting firm of the Company for its fiscal year ending December 31, 2026. Audit-related |
Board | For | FOR 5 funds |
Split 2 FOR, 1 ABSTAIN |
| ARDELYX, INC | June 16, 2026 | To approve the amendment to the Amended and Restated 2014 Equity Incentive Award Plan, or the Restated Plan, to increase the maximum number of shares of common stock that may be delivered pursuant to awards granted under the Restated Plan by 9,000,000 shares. Compensation |
Board | For | AGAINST 1 fund |
Split 1 AGAINST, 1 ABSTAIN |
| ARDELYX, INC | June 16, 2026 | To approve, on a non-binding, advisory basis, the compensation of our named executive officers as disclosed in the proxy statement accompanying this notice pursuant to the compensation disclosure rules of the Securities and Exchange Commission (''Say-on-Pay''); Say-on-Pay |
Board | For | AGAINST 2 funds |
Split 1 FOR, 1 ABSTAIN |
| ARDELYX, INC | June 16, 2026 | To ratify the appointment, by the Audit and Compliance Committee of our Board of Directors, of Ernst & Young LLP as the independent registered public accounting firm of the Company for the fiscal year ending December 31, 2026; and Audit-related |
Board | For | FOR 1 fund |
Split 1 FOR, 1 ABSTAIN |
| ARES MANAGEMENT CORPORATION | June 8, 2026 | The ratification of the selection of Ernst & Young LLP as our independent registered public accounting firm for our 2026 fiscal year. Audit-related |
Board | For | FOR 3 funds |
Split 4 FOR, 2 ABSTAIN |
| ARGAN, INC. | June 10, 2026 | The ratification of the appointment of Grant Thornton LLP as our independent registered public accountants for the fiscal year ending January 31, 2027. Audit-related |
Board | For | FOR 20 funds |
Split 4 FOR, 2 ABSTAIN |
| ARHAUS, INC. | May 14, 2026 | To approve the selection of PricewaterhouseCoopers LLP as the Company's independent accountants for the Company's fiscal year ending December 31, 2026; Audit-related |
Board | For | FOR 8 funds |
Split 1 FOR, 1 ABSTAIN |
| ARISTA NETWORKS, INC. | May 29, 2026 | Approval, on an advisory basis, of the compensation of our named executive officers. Say-on-Pay |
Board | For | AGAINST 10 funds |
Split 4 FOR, 5 AGAINST, 5 ABSTAIN |
| ARISTA NETWORKS, INC. | May 29, 2026 | Ratification of the appointment of Ernst & Young LLP as our independent registered public accounting firm for our fiscal year ending December 31, 2026. Audit-related |
Board | For | FOR 9 funds |
Split 9 FOR, 5 ABSTAIN |
| ARM HOLDINGS PLC | September 9, 2025 | Approve Remuneration Report Say-on-Pay |
Board | For | FOR 8 funds |
Split 1 FOR, 1 AGAINST |
| ARMSTRONG WORLD INDUSTRIES, INC. | June 11, 2026 | To approve, on an advisory basis, our executive compensation program. Say-on-Pay |
Board | For | FOR 11 funds |
Split 5 FOR, 1 ABSTAIN |
| ARMSTRONG WORLD INDUSTRIES, INC. | June 11, 2026 | To ratify the selection of KPMG LLP as our independent registered public accounting firm for 2026. Audit-related |
Board | For | FOR 10 funds |
Split 4 FOR, 1 AGAINST, 1 ABSTAIN |
| ARROW ELECTRONICS, INC. | May 12, 2026 | To approve, by non-binding vote, named executive officer compensation. Say-on-Pay |
Board | For | FOR 11 funds |
Split 2 FOR, 2 ABSTAIN |
| ARROW ELECTRONICS, INC. | May 12, 2026 | To ratify the appointment of Ernst & Young LLP as Arrow's independent registered public accounting firm for the fiscal year ending December 31, 2026. Audit-related |
Board | For | FOR 10 funds |
Split 2 FOR, 2 ABSTAIN |
| ARROWHEAD PHARMACEUTICALS, INC. | March 19, 2026 | Advisory Vote to Approve Executive Compensation. Say-on-Pay |
Board | For | FOR 5 funds |
Split 4 AGAINST, 2 ABSTAIN |
| ARROWHEAD PHARMACEUTICALS, INC. | March 19, 2026 | Approval of the Arrowhead Pharmaceuticals, Inc. Amended and Restated 2021 Incentive Plan. Compensation |
Board | For | FOR 4 funds |
Split 4 FOR, 2 ABSTAIN |
| ARROWHEAD PHARMACEUTICALS, INC. | March 19, 2026 | Ratification of the selection of KPMG LLP as independent auditors of the Company for the fiscal year ending September 30, 2026. Audit-related |
Board | For | FOR 4 funds |
Split 4 FOR, 2 ABSTAIN |
| ARTHUR J. GALLAGHER & CO. | May 12, 2026 | Approval, on an Advisory Basis, of the Compensation of our Named Executive Officers. Say-on-Pay |
Board | For | FOR 7 funds |
Split 3 FOR, 1 AGAINST, 2 ABSTAIN |
| ARTHUR J. GALLAGHER & CO. | May 12, 2026 | Ratification of the Appointment of Ernst & Young LLP as our Independent Auditor for the fiscal year ending December 31, 2026. Audit-related |
Board | For | FOR 6 funds |
Split 4 FOR, 2 ABSTAIN |
| ARVINAS, INC. | June 24, 2026 | Ratification of the appointment of Deloitte & Touche LLP as the Company's Independent registered public accounting firm for the fiscal year ending December 31, 2026. Audit-related |
Board | For | FOR 5 funds |
Split 2 FOR, 1 ABSTAIN |
| ARVINAS, INC. | June 24, 2026 | To approve, on an advisory basis, the compensation of the Company's named executive officers. Say-on-Pay |
Board | For | AGAINST 6 funds |
Split 2 FOR, 1 ABSTAIN |
| ASANA, INC. | June 8, 2026 | Ratification of the appointment of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm for the fiscal year ending January 31, 2027. Audit-related |
Board | For | FOR 1 fund |
Split 2 FOR, 1 ABSTAIN |
| ASBURY AUTOMOTIVE GROUP, INC. | May 4, 2026 | Approval, on an advisory basis, of the compensation of our named executive officers. Say-on-Pay |
Board | For | FOR 8 funds |
Split 5 FOR, 1 ABSTAIN |
| ASBURY AUTOMOTIVE GROUP, INC. | May 4, 2026 | Ratification of the appointment of Ernst & Young LLP as our independent registered public accounting firm for the year ending December 31, 2026. Audit-related |
Board | For | FOR 7 funds |
Split 5 FOR, 1 ABSTAIN |
| ASHLAND INC. | January 20, 2026 | ELECTION OF DIRECTORS: Ashish K. Kulkarni Director Elections |
Board | For | FOR 8 funds |
Split 2 FOR, 1 ABSTAIN |
| ASHLAND INC. | January 20, 2026 | ELECTION OF DIRECTORS: Guillermo Novo Director Elections |
Board | For | FOR 8 funds |
Split 2 FOR, 1 ABSTAIN |
| ASHLAND INC. | January 20, 2026 | ELECTION OF DIRECTORS: Jerome A. Peribere Director Elections |
Board | For | FOR 8 funds |
Split 2 FOR, 1 ABSTAIN |
| ASHLAND INC. | January 20, 2026 | ELECTION OF DIRECTORS: Sanat Chattopadhyay Director Elections |
Board | For | FOR 8 funds |
Split 2 FOR, 1 ABSTAIN |
| ASHLAND INC. | January 20, 2026 | ELECTION OF DIRECTORS: Scott A. Tozier Director Elections |
Board | For | FOR 8 funds |
Split 2 FOR, 1 ABSTAIN |
| ASHLAND INC. | January 20, 2026 | ELECTION OF DIRECTORS: Steven D. Bishop Director Elections |
Board | For | FOR 8 funds |
Split 2 FOR, 1 ABSTAIN |
| ASHLAND INC. | January 20, 2026 | ELECTION OF DIRECTORS: Susan L. Main Director Elections |
Board | For | FOR 8 funds |
Split 2 FOR, 1 ABSTAIN |
| ASHLAND INC. | January 20, 2026 | ELECTION OF DIRECTORS: Suzan F. Harrison Director Elections |
Board | For | FOR 8 funds |
Split 2 FOR, 1 ABSTAIN |
| ASR NEDERLAND N.V | May 20, 2026 | Elect Marco Keim to Supervisory Board Director Elections |
Board | For | FOR 7 funds |
Split 2 FOR, 1 AGAINST |
| ASSA ABLOY AB | April 28, 2026 | Approve Remuneration Report Compensation |
Board | For | FOR 3 funds |
Split 2 FOR, 1 AGAINST |
| ASSA ABLOY AB | April 28, 2026 | Reelect Johan Hjertonsson (Chair), Carl Douglas (Vice Chair), Erik Ekudden, Sofia Schorling Hogberg, Lena Olving, Victoria Van Camp and Susanne Pahlen Aklundh as Directors; Elect Astrid Mozes and Jurgen Timperman as New Directors Director Elections |
Board | For | AGAINST 3 funds |
Split 1 FOR, 2 AGAINST |
| ASSOCIATED BANC-CORP | April 28, 2026 | Advisory approval of Associated Banc-Corp's named executive officer compensation. Say-on-Pay |
Board | For | FOR 9 funds |
Split 6 FOR, 1 ABSTAIN |
| ASSOCIATED BANC-CORP | April 28, 2026 | The ratification of the selection of KPMG LLP as the independent registered public accounting firm for Associated Banc-Corp for the year ending December 31, 2026. Audit-related |
Board | For | FOR 8 funds |
Split 6 FOR, 1 ABSTAIN |
| ASSURANT, INC. | May 21, 2026 | Advisory approval of the fiscal year 2025 compensation of the Company's named executive officers. Say-on-Pay |
Board | For | FOR 11 funds |
Split 5 FOR, 1 AGAINST, 1 ABSTAIN |
| ASSURANT, INC. | May 21, 2026 | Approval of an amendment to the Assurant, Inc. 2017 long term equity incentive plan. Compensation |
Board | For | FOR 10 funds |
Split 6 FOR, 1 ABSTAIN |
| ASSURANT, INC. | May 21, 2026 | Election of Directors: Elaine D. Rosen Director Elections |
Board | For | FOR 10 funds |
Split 6 FOR, 1 ABSTAIN |
| ASSURANT, INC. | May 21, 2026 | Election of Directors: Harriet Edelman Director Elections |
Board | For | FOR 10 funds |
Split 6 FOR, 1 ABSTAIN |
| ASSURANT, INC. | May 21, 2026 | Election of Directors: J. Braxton Carter Director Elections |
Board | For | FOR 10 funds |
Split 6 FOR, 1 ABSTAIN |
| ASSURANT, INC. | May 21, 2026 | Election of Directors: Keith W. Demmings Director Elections |
Board | For | FOR 10 funds |
Split 6 FOR, 1 ABSTAIN |
| ASSURANT, INC. | May 21, 2026 | Election of Directors: Kevin M. Warren Director Elections |
Board | For | FOR 10 funds |
Split 6 FOR, 1 ABSTAIN |
| ASSURANT, INC. | May 21, 2026 | Election of Directors: Lynn S. Blake Director Elections |
Board | For | FOR 10 funds |
Split 6 FOR, 1 ABSTAIN |
| ASSURANT, INC. | May 21, 2026 | Election of Directors: Ognjen (Ogi) Redzic Director Elections |
Board | For | FOR 10 funds |
Split 6 FOR, 1 ABSTAIN |
| ASSURANT, INC. | May 21, 2026 | Election of Directors: Paul J. Reilly Director Elections |
Board | For | FOR 10 funds |
Split 6 FOR, 1 ABSTAIN |
| ASSURANT, INC. | May 21, 2026 | Election of Directors: Rajiv Basu Director Elections |
Board | For | FOR 10 funds |
Split 6 FOR, 1 ABSTAIN |
| ASSURANT, INC. | May 21, 2026 | Election of Directors: Sari Granat Director Elections |
Board | For | FOR 10 funds |
Split 6 FOR, 1 ABSTAIN |
| ASSURANT, INC. | May 21, 2026 | Ratification of the appointment of PricewaterhouseCoopers LLP as Assurant's independent registered public accounting firm for fiscal year 2026. Audit-related |
Board | For | FOR 10 funds |
Split 6 FOR, 1 ABSTAIN |
| ASSURED GUARANTY LTD. | May 1, 2026 | Appoint PricewaterhouseCoopers LLP as the independent auditor of Assured Guaranty Re Ltd. for the fiscal year ending December 31, 2026 Audit-related |
Board | For | FOR 8 funds |
Split 2 FOR, 1 ABSTAIN |
| ASSURED GUARANTY LTD. | May 1, 2026 | Appointment of PricewaterhouseCoopers LLP as the Company's independent auditor for the fiscal year ending December 31, 2026 and authorization of the Board of Directors, acting through its Audit Committee, to set the fees for the independent auditor Audit-related |
Board | For | FOR 8 funds |
Split 2 FOR, 1 ABSTAIN |
| AST SPACEMOBILE, INC. | June 12, 2026 | To approve the non-binding advisory resolution on the compensation paid to the Company's named executive officers. Say-on-Pay |
Board | For | AGAINST 3 funds |
Split 1 FOR, 2 AGAINST, 1 ABSTAIN |
| AST SPACEMOBILE, INC. | June 12, 2026 | To ratify the appointment of KPMG LLP as the Company's independent registered public accounting firm for fiscal year 2026. Audit-related |
Board | For | FOR 2 funds |
Split 3 FOR, 1 ABSTAIN |
| ASTERA LABS, INC. | June 4, 2026 | To approve, on an advisory basis, the compensation of our named executive officers ("NEOs") as disclosed in our proxy materials. Say-on-Pay |
Board | For | Split 4 FOR, 4 AGAINST |
Split 3 FOR, 1 AGAINST |
| ASTERA LABS, INC. | June 4, 2026 | To ratify the appointment of PricewaterhouseCoopers LLP as the independent registered public accounting firm of the Company for the fiscal year ending December 31, 2026. Audit-related |
Board | For | FOR 8 funds |
Split 4 FOR, 2 ABSTAIN |
| ASTRANA HEALTH, INC. | June 10, 2026 | To approve the Astrana Health, Inc. Amended and Restated 2024 Equity Incentive Plan. Compensation |
Board | For | FOR 2 funds |
Split 2 FOR, 1 ABSTAIN |
| ASTRANA HEALTH, INC. | June 10, 2026 | To approve, on a non-binding advisory basis, the compensation program for the Company's named executive officers as disclosed in the Company's proxy statement. Say-on-Pay |
Board | For | FOR 3 funds |
Split 2 FOR, 1 ABSTAIN |
| ASTRANA HEALTH, INC. | June 10, 2026 | To ratify the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026. Audit-related |
Board | For | FOR 2 funds |
Split 2 FOR, 1 ABSTAIN |
| ASTRIA THERAPEUTICS, INC. | January 21, 2026 | To cast a vote, on a non-binding, advisory basis, to approve the Merger-related named executive officer compensation as disclosed in the table entitled ''Golden Parachute Compensation'' and its accompanying footnotes which is included in the section of the proxy statement entitled ''The Merger-Interests of Astia's Directors and Executive Officers in the Merger,'' as required by Section 14A of the Securities Exchange Act of 1934, as amended, which was enacted as part of the Dodd-Frank Wall Street Reform and Consumer Protection Act of 2010. Say-on-Pay |
Board | For | AGAINST 4 funds |
Split 1 FOR, 1 ABSTAIN |
| ASTRONICS CORPORATION | May 28, 2026 | To approve the adoption of the Astronics Corporation 2026 Employee Stock Purchase Plan. Compensation |
Board | For | FOR 13 funds |
Split 2 FOR, 1 AGAINST |
| ASTRONICS CORPORATION | May 28, 2026 | To approve the advisory resolution indicating the approval of the Compensation of the Company's named executive officers. Say-on-Pay |
Board | For | FOR 14 funds |
Split 2 FOR, 1 ABSTAIN |
| ASTRONICS CORPORATION | May 28, 2026 | To ratify the appointment of Ernst & Young LLP as the independent registered public accounting firm for the Company for the fiscal year ending December 31, 2026. Audit-related |
Board | For | FOR 13 funds |
Split 2 FOR, 1 ABSTAIN |
| AT&T INC | May 14, 2026 | Advisory approval of executive compensation Say-on-Pay |
Board | For | FOR 8 funds |
Split 5 FOR, 1 AGAINST, 6 ABSTAIN |
| AT&T INC. | May 14, 2026 | Approve 2026 Incentive Plan Compensation |
Board | For | Split 1 FOR, 6 AGAINST |
FOR 12 funds |
| AT&T INC. | May 14, 2026 | Election of Directors: Beth E. Mooney Director Elections |
Board | For | FOR 7 funds |
Split 5 FOR, 6 ABSTAIN |
| AT&T INC. | May 14, 2026 | Election of Directors: Cynthia B. Taylor Director Elections |
Board | For | FOR 7 funds |
Split 5 FOR, 6 ABSTAIN |
| AT&T INC. | May 14, 2026 | Election of Directors: John T. Stankey Director Elections |
Board | For | FOR 7 funds |
Split 5 FOR, 6 ABSTAIN |
| AT&T INC. | May 14, 2026 | Election of Directors: Kelly J. Grier Director Elections |
Board | For | FOR 7 funds |
Split 5 FOR, 6 ABSTAIN |
| AT&T INC. | May 14, 2026 | Election of Directors: Marissa A. Mayer Director Elections |
Board | For | FOR 7 funds |
Split 5 FOR, 6 ABSTAIN |
| AT&T INC. | May 14, 2026 | Election of Directors: Matthew K. Rose Director Elections |
Board | For | FOR 7 funds |
Split 5 FOR, 6 ABSTAIN |
| AT&T INC. | May 14, 2026 | Election of Directors: Michael B. McCallister Director Elections |
Board | For | FOR 7 funds |
Split 5 FOR, 6 ABSTAIN |
| AT&T INC. | May 14, 2026 | Election of Directors: Stephen J. Luczo Director Elections |
Board | For | FOR 7 funds |
Split 5 FOR, 6 ABSTAIN |
| AT&T INC. | May 14, 2026 | Election of Directors: William E. Kennard Director Elections |
Board | For | FOR 7 funds |
Split 5 FOR, 6 ABSTAIN |
| AT&T INC. | May 14, 2026 | Ratification of the Appointment of Ernst & Young LLP as Independent Auditors Audit-related |
Board | For | FOR 7 funds |
Split 5 FOR, 1 AGAINST, 6 ABSTAIN |
| AT&T Inc. | May 14, 2026 | Election of Directors: Luis A. Ubinas Director Elections |
Board | For | FOR 7 funds |
Split 3 FOR, 6 ABSTAIN |
| ATEA PHARMACEUTICALS, INC. | June 18, 2026 | Approval, on an advisory (non-binding) basis, of the compensation of the named executive officers of the Company. Say-on-Pay |
Board | For | AGAINST 5 funds |
Split 3 FOR, 1 ABSTAIN |
| ATI INC. | May 14, 2026 | Advisory vote to approve the compensation of our named executive officers Say-on-Pay |
Board | For | FOR 16 funds |
Split 7 FOR, 2 ABSTAIN |
| ATI INC. | May 14, 2026 | Election of Directors: David J. Morehouse Director Elections |
Board | For | FOR 15 funds |
Split 5 FOR, 4 WITHHOLD |
| ATI INC. | May 14, 2026 | Election of Directors: Elizabeth H. Lund Director Elections |
Board | For | FOR 15 funds |
Split 7 FOR, 2 WITHHOLD |
| ATI INC. | May 14, 2026 | Election of Directors: Kimberly A. Fields Director Elections |
Board | For | FOR 15 funds |
Split 7 FOR, 2 WITHHOLD |
| ATI INC. | May 14, 2026 | Ratification of the election of Ernst & Young LLP as our independent auditors for 2026 Audit-related |
Board | For | FOR 15 funds |
Split 6 FOR, 1 AGAINST, 2 ABSTAIN |
| ATLANTIC UNION BANKSHARES CORPORATION | May 5, 2026 | To elect directors to serve until the 2027 annual meeting of shareholders: Daniel J. Schrider Director Elections |
Board | For | FOR 7 funds |
Split 2 FOR, 1 ABSTAIN |
| ATLANTIC UNION BANKSHARES CORPORATION | May 5, 2026 | To elect directors to serve until the 2027 annual meeting of shareholders: Donald R. Kimble Director Elections |
Board | For | FOR 7 funds |
Split 2 FOR, 1 ABSTAIN |
| ATLANTIC UNION BANKSHARES CORPORATION | May 5, 2026 | To elect directors to serve until the 2027 annual meeting of shareholders: F. Blair Wimbush Director Elections |
Board | For | FOR 7 funds |
Split 2 FOR, 1 ABSTAIN |
| ATLANTIC UNION BANKSHARES CORPORATION | May 5, 2026 | To elect directors to serve until the 2027 annual meeting of shareholders: Frank Russell Ellett Director Elections |
Board | For | FOR 7 funds |
Split 2 FOR, 1 ABSTAIN |
← Previous Page 6 of 100 Next →
How items are matched and positions counted: see the comparison table and the methodology. Built October 25, 2026 from SEC Form N-PX filings.